Autopsy report · NCT00065572
Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV)
Cause of deathNo reason given
Life of this trial
- Suspended: paused, and may or may not restart.
Vital statistics
- Status
- Suspended
- Phase
- Phase 2
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Carcinoma, Renal Cell; Kidney Neoplasms
- Interventions
- ZD6126; Placebo
- Sites
- 16
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.